Tour de France Doping Tests: Pogacar and Vingegaard Woken at Nigh 2026

The recent Tour de France doping tests that forced leaders Tadej Pogacar and Jonas Vingegaard out of bed in the early hours have sparked widespread debate. A Paris judge authorised the night-time controls under strict conditions, raising questions about fairness and athlete welfare.

Background of the Night-Time Doping Tests

The International Testing Agency (ITA) petitioned a Paris judge to authorise tests outside the normal window of 6am to 11pm. The judge, specialising in liberty and detention matters, granted permission for the controls to take place overnight between July 18 and 19, before Stage 15 to Plateau de Solaison.

Under UCI anti-doping regulations, such tests require “serious and specific suspicions” of doping. The ITA argued that extraordinary circumstances justified the early-morning disruptions, but critics contend the process lacks respect for riders.

Impact on Riders and Race Dynamics

Vingegaard was tested at 2am, while Pogacar received his wake-up call at 5am. Pogacar described Vingegaard's 2am test as “inhuman” and speculated it could have contributed to Vingegaard's crash on Sunday, which ended his Tour with a broken collarbone. Vingegaard himself said, “I was sleeping very well. It’s good that they test, but when it’s affecting performance and your sleep, I don’t think it’s so good.”

Other riders, including Remco Evenepoel and Matteo Jorgenson, condemned the timing, with Jorgenson calling it “a complete lack of respect.” The ITA acknowledged the disruption but maintained that testing integrity is paramount.

Comparison of Testing Rules and Practices

Key Takeaways from the Incident

• Night-time doping tests require judicial authorisation under French law.
• Riders’ sleep and performance can be negatively impacted, raising ethical concerns.
• The ITA defended the tests as necessary for fair competition, but the cycling community largely criticised them.
• This case highlights the tension between anti-doping efforts and athlete welfare.

FAQ

The controversy underscores the delicate balance between rigorous anti-doping enforcement and the well-being of athletes. As the Tour de France continues, the debate over appropriate testing protocols is far from over.